Matches in SemOpenAlex for { <https://semopenalex.org/work/W4308978013> ?p ?o ?g. }
Showing items 1 to 73 of
73
with 100 items per page.
- W4308978013 endingPage "vii271" @default.
- W4308978013 startingPage "vii271" @default.
- W4308978013 abstract "Abstract INTRODUCTION Little is known about tumour-infiltrating lymphocytes (TILs) in brain metastasis (BM) and their utility as predictive biomarker for immunotherapy. AIM: To analyze TILs in BM, and correlate with corresponding paired primary (PP). METHODS Inclusion: Histologically confirmed BM and PP (2015-2020). Exclusion: Hematological malignancies, spinal cord/meningeal metastasis, pediatric age, slides/blocks not available. Final Nf 277 BM; 64 PP. One H&E slide from both PP &BM assessed for stromal TILs (sTILs) and intratumoral TILs (iTILs) as per International TIL Working Group guidelines. RESULTS Median sTILs (10%) were significantly higher than iTILs (1%) in primary and BM (p-value < 0.001). sTILs were mild (<10%) in majority of primary (57.8%) and BM (59.9%), while iTILs were nearly always mild (primary 97.1%; BM 96.9%). Between PP and BM, no change in sTIL category in 48.43%, while conversion in 51.56%, with higher to lower conversion (66.67%) > lower to higher (33.33%). Conversion rate higher for breast (54.3%) &GIT (62.5%) than lung (45.5%) &GUT (40%). In BM, preoperative steroid therapy (PST) showed lower sTILs (≤10%) (p-value= 0.041), and adenocarcinoma histology higher sTILs ( >10%) (p-value= 0.001), while precocious metastasis (p-value= 0.051) and absence of extracranial metastasis (p-value= 0.083) trended towards higher sTILs. Median survival of whole cohort was 20 months (95% CI 14.4-25.68 months). Presence of extracranial metastasis (p-value= 0.01); precocious BM (p-value= 0.007) showed lower overall survival (OS), while adenocarcinoma histology better OS (p-value= 0.029), in both univariate and multivariate analysis. Absence of PST showed longer median survival, though not significant (24.1 vs 19.8months; p-value= 0.19). CONCLUSIONS sTILs predominantly show high >low conversion between PP and BM, signifying lowered immune response in BM. Thus, evaluation of sTILs in BM, wherever tissue available, may be indicated if immunotherapy is considered. Parameters with higher sTILs showed longer survival, possibly indicating prognostic role of tumor microenvironment in BM." @default.
- W4308978013 created "2022-11-20" @default.
- W4308978013 creator A5000975967 @default.
- W4308978013 creator A5014065182 @default.
- W4308978013 creator A5026561387 @default.
- W4308978013 creator A5028341899 @default.
- W4308978013 creator A5032568030 @default.
- W4308978013 creator A5032979380 @default.
- W4308978013 creator A5033434500 @default.
- W4308978013 creator A5053748601 @default.
- W4308978013 creator A5057836119 @default.
- W4308978013 creator A5066919563 @default.
- W4308978013 creator A5090905342 @default.
- W4308978013 creator A5091702113 @default.
- W4308978013 date "2022-11-01" @default.
- W4308978013 modified "2023-09-29" @default.
- W4308978013 title "TMIC-03. TUMOR INFILTRATING LYMPHOCYTES IN BRAIN METASTASIS: CLINICOPATHOLOGICAL EVALUATION AND COMPARISON WITH PAIRED PRIMARY" @default.
- W4308978013 doi "https://doi.org/10.1093/neuonc/noac209.1047" @default.
- W4308978013 hasPublicationYear "2022" @default.
- W4308978013 type Work @default.
- W4308978013 citedByCount "0" @default.
- W4308978013 crossrefType "journal-article" @default.
- W4308978013 hasAuthorship W4308978013A5000975967 @default.
- W4308978013 hasAuthorship W4308978013A5014065182 @default.
- W4308978013 hasAuthorship W4308978013A5026561387 @default.
- W4308978013 hasAuthorship W4308978013A5028341899 @default.
- W4308978013 hasAuthorship W4308978013A5032568030 @default.
- W4308978013 hasAuthorship W4308978013A5032979380 @default.
- W4308978013 hasAuthorship W4308978013A5033434500 @default.
- W4308978013 hasAuthorship W4308978013A5053748601 @default.
- W4308978013 hasAuthorship W4308978013A5057836119 @default.
- W4308978013 hasAuthorship W4308978013A5066919563 @default.
- W4308978013 hasAuthorship W4308978013A5090905342 @default.
- W4308978013 hasAuthorship W4308978013A5091702113 @default.
- W4308978013 hasBestOaLocation W43089780131 @default.
- W4308978013 hasConcept C121608353 @default.
- W4308978013 hasConcept C126322002 @default.
- W4308978013 hasConcept C142724271 @default.
- W4308978013 hasConcept C143998085 @default.
- W4308978013 hasConcept C2779013556 @default.
- W4308978013 hasConcept C2780283643 @default.
- W4308978013 hasConcept C57742111 @default.
- W4308978013 hasConcept C71924100 @default.
- W4308978013 hasConcept C90924648 @default.
- W4308978013 hasConceptScore W4308978013C121608353 @default.
- W4308978013 hasConceptScore W4308978013C126322002 @default.
- W4308978013 hasConceptScore W4308978013C142724271 @default.
- W4308978013 hasConceptScore W4308978013C143998085 @default.
- W4308978013 hasConceptScore W4308978013C2779013556 @default.
- W4308978013 hasConceptScore W4308978013C2780283643 @default.
- W4308978013 hasConceptScore W4308978013C57742111 @default.
- W4308978013 hasConceptScore W4308978013C71924100 @default.
- W4308978013 hasConceptScore W4308978013C90924648 @default.
- W4308978013 hasIssue "Supplement_7" @default.
- W4308978013 hasLocation W43089780131 @default.
- W4308978013 hasOpenAccess W4308978013 @default.
- W4308978013 hasPrimaryLocation W43089780131 @default.
- W4308978013 hasRelatedWork W1588862007 @default.
- W4308978013 hasRelatedWork W1969191615 @default.
- W4308978013 hasRelatedWork W1970010079 @default.
- W4308978013 hasRelatedWork W2393830862 @default.
- W4308978013 hasRelatedWork W2408693058 @default.
- W4308978013 hasRelatedWork W2898349062 @default.
- W4308978013 hasRelatedWork W2914514705 @default.
- W4308978013 hasRelatedWork W2955868701 @default.
- W4308978013 hasRelatedWork W3084954160 @default.
- W4308978013 hasRelatedWork W4323652062 @default.
- W4308978013 hasVolume "24" @default.
- W4308978013 isParatext "false" @default.
- W4308978013 isRetracted "false" @default.
- W4308978013 workType "article" @default.